Dare Bioscience, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum
Dare Bioscience, Inc. (DARE) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum of 1.70% for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-13.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum · last filed 2017-11-13
- Dare Bioscience, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2016-09-30 was 1.20%, a 27.27% decline year-over-year.
- Dare Bioscience, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2016-03-31 was 1.30%, a 10.34% decline year-over-year.
- Dare Bioscience, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2015-09-30 was 1.65%, a 11.29% decline year-over-year.
- Dare Bioscience, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2015-06-30 was 1.80%, a 5.26% decline year-over-year.
- Dare Bioscience, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2016 was 1.20%, a 17.24% decline from fiscal 2015.
- Dare Bioscience, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2015 was 1.45%, a 15.20% decline from fiscal 2014.
- Dare Bioscience, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2014 was 1.71%, a 56.88% increase from fiscal 2013.
- Dare Bioscience, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2013 was 1.09%, a 31.33% increase from fiscal 2012.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 12 month |
|---|---|---|---|---|---|---|---|
| 2017-09-30 | 1.70% 10-Q · filed 2017-11-13 | ||||||
| 2016-12-31 | 1.20% 10-K/A · filed 2017-06-13 | ||||||
| 2016-09-30 | 1.20% 10-Q · filed 2016-11-03 | 1.20% 10-Q · filed 2016-11-03 | |||||
| 2016-06-30 | 1.20% 10-Q · filed 2017-08-14 | ||||||
| 2016-03-31 | 1.30% 10-Q · filed 2017-05-12 | 1.31% 10-Q · filed 2016-05-02 | |||||
| 2015-12-31 | 1.45% 10-K/A · filed 2017-06-13 | ||||||
| 2015-09-30 | 1.65% 10-Q · filed 2015-11-16 | 1.50% 10-Q · filed 2016-11-03 | 1.45% 10-Q · filed 2015-11-16 | ||||
| 2015-06-30 | 1.80% 10-Q · filed 2016-08-04 | 1.50% 10-Q · filed 2016-08-04 | |||||
| 2015-03-31 | 1.45% 10-Q · filed 2016-05-02 | ||||||
| 2014-12-31 | 1.71% 10-K/A · filed 2017-06-13 | ||||||
| 2014-09-30 | 1.86% 10-Q · filed 2015-11-16 | 1.83% 10-Q · filed 2015-11-16 | |||||
| 2014-06-30 | 1.90% 10-Q · filed 2015-08-06 | 1.93% 10-Q · filed 2014-08-12 | 1.80% 10-Q · filed 2015-08-06 | 1.83% 10-Q · filed 2014-08-12 | |||
| 2014-03-31 | 1.83% 10-Q · filed 2015-05-06 | ||||||
| 2013-12-31 | 1.09% 10-K · filed 2016-03-10 | ||||||
| 2012-12-31 | 0.83% 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |